1. Home
  2. DH vs PRTC Comparison

DH vs PRTC Comparison

Compare DH & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • PRTC
  • Stock Information
  • Founded
  • DH 2011
  • PRTC 2015
  • Country
  • DH United States
  • PRTC United States
  • Employees
  • DH 782
  • PRTC N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DH Technology
  • PRTC Health Care
  • Exchange
  • DH Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • DH 332.0M
  • PRTC 355.3M
  • IPO Year
  • DH 2021
  • PRTC N/A
  • Fundamental
  • Price
  • DH $3.20
  • PRTC $19.00
  • Analyst Decision
  • DH Hold
  • PRTC
  • Analyst Count
  • DH 5
  • PRTC 0
  • Target Price
  • DH $4.35
  • PRTC N/A
  • AVG Volume (30 Days)
  • DH 342.8K
  • PRTC 4.9K
  • Earning Date
  • DH 11-06-2025
  • PRTC 08-28-2025
  • Dividend Yield
  • DH N/A
  • PRTC N/A
  • EPS Growth
  • DH N/A
  • PRTC N/A
  • EPS
  • DH N/A
  • PRTC 0.20
  • Revenue
  • DH $244,926,000.00
  • PRTC $6,391,000.00
  • Revenue This Year
  • DH N/A
  • PRTC N/A
  • Revenue Next Year
  • DH $0.68
  • PRTC N/A
  • P/E Ratio
  • DH N/A
  • PRTC $8.78
  • Revenue Growth
  • DH N/A
  • PRTC 1265.60
  • 52 Week Low
  • DH $2.15
  • PRTC $13.30
  • 52 Week High
  • DH $5.68
  • PRTC $24.99
  • Technical
  • Relative Strength Index (RSI)
  • DH 32.45
  • PRTC 63.84
  • Support Level
  • DH $3.16
  • PRTC $18.68
  • Resistance Level
  • DH $4.06
  • PRTC $19.08
  • Average True Range (ATR)
  • DH 0.20
  • PRTC 0.37
  • MACD
  • DH -0.09
  • PRTC 0.34
  • Stochastic Oscillator
  • DH 4.20
  • PRTC 95.74

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: